Alessandro Inno
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Cancer Research top 10%
- Pathology and Forensic Medicine top 10%
- Co-authors
- Stefania GoriAntonio RussoFausto PetrelliAntonio GhidiniLorenzo BelluominiSimona DurantiZeno BisoffiGuido Arcaro
- Topics
- Cancer Immunotherapy and Biomarkers (20 papers)Colorectal Cancer Treatments and Studies (15 papers)Chemotherapy-induced cardiotoxicity and mitigation (14 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaInternational Journal of Molecular Sciences
- Partner nations
- ItalyUnited StatesJapan
In The Last Decade
Alessandro Inno
76 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 92
- Oncology 695
- Pulmonary and Respiratory Medicine 329
- Molecular Biology 258
- Cancer Research 184
- Pathology and Forensic Medicine 154
Countries citing papers authored by Alessandro Inno
This map shows the geographic impact of Alessandro Inno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Inno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Inno more than expected).
Fields of papers citing papers by Alessandro Inno
This network shows the impact of papers produced by Alessandro Inno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Inno. The network helps show where Alessandro Inno may publish in the future.
Co-authorship network of co-authors of Alessandro Inno
This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Inno. A scholar is included among the top collaborators of Alessandro Inno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Inno. Alessandro Inno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 10 | |
| 5 | 9 | |
| 6 | 9 | |
| 7 | 7 | |
| 8 | 3 | |
| 9 | 0 | |
| 10 | 5 | |
| 11 | 13 | |
| 12 | 11 | |
| 13 | 7 | |
| 14 | 24 | |
| 15 | 3 | |
| 16 | 2 | |
| 17 | 24 | |
| 18 | 15 | |
| 19 | 13 | |
| 20 | 3 |
About Alessandro Inno
Alessandro Inno is a scholar working on Oncology, Cancer Research and Family Practice, having authored 80 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (20 papers), Colorectal Cancer Treatments and Studies (15 papers) and Chemotherapy-induced cardiotoxicity and mitigation (14 papers). The work is most often cited by research in Oncology (695 citations), Cancer Research (184 citations) and Pulmonary and Respiratory Medicine (329 citations). Alessandro Inno has collaborated with scholars based in Italy, United States and Japan. Frequent co-authors include Stefania Gori, Antonio Russo, Fausto Petrelli, Antonio Ghidini, Lorenzo Belluomini, Simona Duranti, Zeno Bisoffi, Guido Arcaro, Paolo Bocus and Monica Turazza. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.